| VP-0059 |
SCIG (immune globulin SQ): Hizentra®, Gammagard Liquid®, Gamunex®-C, Gammaked®, Hyqvia®, Cuvitru®, Cutaquig®, Xembify® (Subcutaneous) |
|
| VP-0071 |
Immune Globulins (immunoglobulin) (Intravenous) |
|
| VP-0072 |
Ixempra® (ixabepilone) (Intravenous) |
|
| VP-0089 |
Nplate™ (romiplostim) (Subcutaneous) |
|
| VP-0092 |
Kadcyla® (ado-trastuzumab emtansine) (Intravenous) |
|
| VP-0100 |
Provenge® (sipuleucel-T) (Intravenous) |
|
| VP-0130 |
Bendamustine: Treanda®; Bendeka®; Belrapzo®; Vivimusta™; Bendamustine Ψ (Intravenous) |
|
| VP-0136 |
Vectibix® (panitumumab) (Intravenous) |
|
| VP-0137 |
Velcade® (bortezomib) (Intravenous/Subcutaneous) |
|
| VP-0157 |
Kyprolis® (carfilzomib) (Intravenous) |
|
| VP-0200 |
Sylvant™ (siltuximab) (Intravenous) |
|
| VP-0208 |
Arzerra® (ofatumumab) (Intravenous) |
|
| VP-0209 |
Keytruda® (pembrolizumab) (Intravenous) |
|
| VP-0243 |
Epoetin alfa: Epogen®; Procrit®; Retacrit® (Subcutaneous/Intravenous) |
|
| VP-0267 |
Portrazza™ (necitumumab) (Intravenous) |
|
| VP-0268 |
Empliciti™ (elotuzumab) (Intravenous) |
|
| VP-0274 |
Imlygic™ (talimogene laherparepvec) Intralesional |
|
| VP-0314 |
Vyxeos® (daunorubicin and cytarabine – liposome) (Intravenous) |
|
| VP-0317 |
Besponsa (inotuzumab ozogamicin) (Intravenous) |
|
| VP-0319 |
Kymriah (tisagenlecleucel) (Intravenous) |
|
| VP-0320 |
Mylotarg (gemtuzumab ozogamicin) (Intravenous) |
|
| VP-0333 |
Yescarta™ (axicabtagene ciloleucel) (Intravenous) |
|
| VP-0367 |
Elitek® (rasburicase) (Intravenous) |
|
| VP-0378 |
Poteligeo® (mogamulizumab-kpkc) (Intravenous) |
|
| VP-0393 |
Lumoxiti™ (moxetumomab pasudotox-tdfk) (Intravenous) |
|
| VP-0449 |
Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk) (Subcutaneous) |
|
| VP-0482 |
Polivy™ (polatuzumab vedotin-piiq) (Intravenous) |
|
| VP-0521 |
Padcev™ (enfortumab vedotin-ejfv) (Intravenous) |
|
| VP-0522 |
Enhertu® (fam-trastuzumab deruxtecan-nxki) (Intravenous) |
|
| VP-0528 |
Sarclisa® (isatuximab-irfc) (Intravenous) |
|
| VP-0531 |
Jelmyto™ (mitomycin) (Intra-pyelocalyceal) |
|
| VP-0547 |
Evomela® (melphalan) (Intravenous) |
|
| VP-0553 |
Phesgo™ (pertuzumab, trastuzumab and hyaluronidase-zzxf) (Subcutaneous) |
|
| VP-0558 |
Tecartus™ (brexucabtagene autoleucel) (Intravenous) |
|
| VP-0559 |
Monjuvi™ (tafasitamab-cxix) (Intravenous) |
|
| VP-0561 |
Blenrep® (belantamab mafodotin-blmf) (Intravenous) |
|
| VP-0581 |
Danyelza® (naxitamab-gqgk) (Intravenous) |
|
| VP-0590 |
Breyanzi® (lisocabtagene maraleucel) (Intravenous) |
|
| VP-0598 |
Abecma® (idecabtagene vicleucel) (Intravenous) |
|
| VP-0607 |
Rybrevant™ (amivantamab-vmjw) (Intravenous) |
|
| VP-0647 |
Fyarro™ (sirolimus albumin-bound) (Intravenous) |
|
| VP-0658 |
Kimmtrak® (tebentafusp-tebn) (Intravenous) |
|
| VP-0663 |
Carvykti™ (ciltacabtagene autoleucel) (Intravenous) |
|
| VP-0664 |
Opdualag™ (nivolumab/relatlimab-rmbw) (Intravenous) |
|
| VP-0692 |
Lunsumio™ (mosunetuzumab-axgb) (Intravenous) |
|
| VP-90014 |
Bevacizumab: Avastin®; Mvasi®; Zirabev™; Alymsys®; Vegzelma™ (Intravenous) |
|
| VP-90057 |
Trastuzumab: Herceptin®; Ogivri®; Kanjinti™; Trazimera™; Herzuma®; Ontruzant® (Intravenous) |
|
| VP-90109 |
Rituximab: Rituxan®, Truxima®, Ruxience™, Riabni™ (Intravenous) |
|
